Autoimmunity and clinical pathology amelioration in SLE by Dexamethasone primed Mesenchymal Stem Cell derived conditioned media
K. priya, S. Rawat, D. Das, M. Chaubey, H. Thacker, K. Giri, S. Singh, M. Rai, S. Mohanty, G. Rai
This study evaluates dexamethasone-primed mesenchymal stem cell conditioned media for treating SLE, showing improved immunomodulation and organ protection compared to standard therapies.
bioRxiv · Jun 29, 2024Immunology